A Study to Investigate the Effect of a Meal At 6pm the Day Before the Colonoscopy on the Bowel Cleansing with Plenvu
DinNER1006
To Dine or Not to Dine: Effect of Day-before Light Dinner on Bowel Cleansing Prior to Colonoscopy
1 other identifier
interventional
525
1 country
1
Brief Summary
Bowel cleansing prior to colonoscopy is crucial to be able to perform a high-quality examination. Therefore maximum efforts are made to achieve optimal bowel cleansing including diet restriction and refraining from day-before dinner. However, the effect of this interdiction is currently not clear. On the other hand, patient compliance and experience with the entire procedure is important, especially for follow-up colonoscopies. Strict diets may interfere with this as an additional burden on the patient. In this study we want to assess whether a more lenient diet influences the quality of bowel preparation and whether it improves patient's experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 14, 2023
CompletedFirst Submitted
Initial submission to the registry
October 18, 2024
CompletedFirst Posted
Study publicly available on registry
October 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedOctober 21, 2024
October 1, 2024
1.7 years
October 18, 2024
October 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with an adequate bowel preparation (BBPS ≥6, and no segmental subscore ≤1)
Max 12 weeks
Secondary Outcomes (4)
Number of patients with an optimal bowel preparation (BBPS 8-9)
Max 12 weeks
Detection rates
Max 12 weeks
Number of patients with high-quality right sided colon preparation (subscore = 3)
Max 12 weeks
Overall patient's tolerance, adherence and satisfaction based on the patient's diary
Max 12 weeks
Study Arms (2)
Lenient diet
EXPERIMENTALThis group can have a less stringent diet compared to the current standard of care and eat a light meal until 18h before drinking the first dose of the bowel preparation on the day before the colonoscopy
Control group
NO INTERVENTIONThis group follows the strict diet similar to what is currently used in standard of care.
Interventions
The interventional goup receives the lenient diet instructions and will eat a light meal until 18h on the day before the colonoscopy. The first dose of Plenvu will be started at 20h. All the other bowel preparation instructions will be the same as in the control group.
Eligibility Criteria
You may qualify if:
- Patient referred for diagnostic colonoscopy
- Age between 40 and 85 years old
- Ability of normal oral ingestion
- Able to give informed consent by the patient or the legal representative
You may not qualify if:
- Participant has a history of (partial) colectomy, excluding appendectomy
- Inability of oral ingestion
- Chronic severe constipation, defined as the need for daily laxative use of any kind or the need to use laxatives to obtain defaecation.
- Uncontrolled coagulopathy
- Pregnancy
- Premenopausal women not adhering to any contraceptive method
- Inflammatory bowel disease
- Lynch syndrome
- Familial adenomatosis polyposis syndrome
- Serrated polyposis syndrome
- hypersensitivity to the active substances of PLENVU as listed in the SmPC section 6.1
- gastrointestinal obstruction or perforation
- ileus
- gastric emptying disorders (e.g. gastroparesis, gastric retention, etc.)
- phenylketonuria (due to the presence of aspartame in PLENVU)
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitaire Ziekenhuizen KU Leuvenlead
- Norgine BVcollaborator
Study Sites (1)
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Masking Details
- The endoscopist who performs the colonoscopy and the investigator who acts as second observer are blinded to objectively assess the BBPS.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2024
First Posted
October 21, 2024
Study Start
February 14, 2023
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
October 21, 2024
Record last verified: 2024-10